Grants to Support Investigator-Initiated Early-Phase Clinical Trials in Virgin Islands (USA)
GrantID: 64183
Grant Funding Amount Low: $250,000
Deadline: October 2, 2026
Grant Amount High: $1,515,000
Summary
The grant aims to accelerate the development of innovative treatments and diagnostic tools for heart, lung, blood, and sleep (HLBS) conditions. The program seeks to catalyze breakthroughs in HLBS research, ultimately improving patient outcomes and advancing medical knowledge...
Those working in Awards and located in Virgin Islands may meet the eligibility criteria for this grant. To browse other funding opportunities suited to your focus areas, visit The Grant Portal and try the Search Grant tool.
Eligible Regions
Interests
Eligible Requirements
